Nanjing Sanhome Pharmaceutical, Co., Ltd.
Quick facts
Phase 3 pipeline
- Placebo Gefitinib · Oncology
This is a placebo control arm, not an active drug, and contains no therapeutic mechanism. - SH-1028 tablets · Unknown
SH-1028 tablets are a small molecule drug that targets the molecular target.
Phase 2 pipeline
Phase 1 pipeline
- [14C] SH-1028
- SH009
- SH1573 Capsules
- SH229
- SH3051 capsule treatment
- SH3765 tablet
- SH3809 tablet
- SHC014748M Capsules
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Nanjing Sanhome Pharmaceutical, Co., Ltd. portfolio CI brief
- Nanjing Sanhome Pharmaceutical, Co., Ltd. pipeline updates RSS
Frequently asked questions about Nanjing Sanhome Pharmaceutical, Co., Ltd.
What is Nanjing Sanhome Pharmaceutical, Co., Ltd.'s pipeline?
Nanjing Sanhome Pharmaceutical, Co., Ltd. has 2 drugs in Phase 3, 5 in Phase 2, 8 in Phase 1. Late-stage candidates include Placebo Gefitinib, SH-1028 tablets.
Related
- Sector hub: All tracked pharma companies